Cargando…

Profile of cystic fibrosis in a single referral center in Egypt

It was generally believed that Cystic fibrosis (CF) is rare among Arabs; however, the few studies available from Egypt and other Arabic countries suggested the presence of many undiagnosed patients. The aim of the present study was to determine the frequency of CF patients out of the referred cases...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Falaki, Mona M., Shahin, Walaa A., El-Basha, Noussa R., Ali, Aliaa A., Mehaney, Dina A., El-Attar, Mona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294314/
https://www.ncbi.nlm.nih.gov/pubmed/25685524
http://dx.doi.org/10.1016/j.jare.2013.07.005
_version_ 1782352705691320320
author El-Falaki, Mona M.
Shahin, Walaa A.
El-Basha, Noussa R.
Ali, Aliaa A.
Mehaney, Dina A.
El-Attar, Mona M.
author_facet El-Falaki, Mona M.
Shahin, Walaa A.
El-Basha, Noussa R.
Ali, Aliaa A.
Mehaney, Dina A.
El-Attar, Mona M.
author_sort El-Falaki, Mona M.
collection PubMed
description It was generally believed that Cystic fibrosis (CF) is rare among Arabs; however, the few studies available from Egypt and other Arabic countries suggested the presence of many undiagnosed patients. The aim of the present study was to determine the frequency of CF patients out of the referred cases in a single referral hospital in Egypt. A total of 100 patients clinically suspected of having CF were recruited from the CF clinic of the Allergy and Pulmonology Unit, Children’s Hospital, Cairo University, Egypt, throughout a 2 year period. Sweat chloride testing was done for all patients using the Wescor macroduct system for collection of sweat. Quantitative analysis for chloride was then done by the thiocyanate colorimetric method. Patients positive for sweat chloride (⩾60 mmol/L) were tested for the ΔF508 mutation using primer specific PCR for cystic fibrosis transmembrane conductance regulator (CFTR) gene. Thirty-six patients (36%) had a positive sweat chloride test. The main clinical presentations in patients were chronic cough in 32 (88.9%), failure to thrive in 27 (75%), steatorrhea in 24 (66.7%), and hepatobiliary involvement in 5 (13.9%). Positive consanguinity was reported in 50% of CF patients. Thirty-two patients were screened for ΔF508 mutation. Positive ΔF508 mutation was detected in 22 (68.8%) patients, 8 (25%) were homozygous, 14 (43.8%) were heterozygous, and 10 (31.3%) tested were negative. CF was diagnosed in more than third of patients suspected of having the disease on clinical grounds. This high frequency of CF among referred patients indicates that a high index of suspicion and an increasing availability of diagnostic tests lead to the identification of a higher number of affected individuals.
format Online
Article
Text
id pubmed-4294314
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-42943142015-02-14 Profile of cystic fibrosis in a single referral center in Egypt El-Falaki, Mona M. Shahin, Walaa A. El-Basha, Noussa R. Ali, Aliaa A. Mehaney, Dina A. El-Attar, Mona M. J Adv Res Original Article It was generally believed that Cystic fibrosis (CF) is rare among Arabs; however, the few studies available from Egypt and other Arabic countries suggested the presence of many undiagnosed patients. The aim of the present study was to determine the frequency of CF patients out of the referred cases in a single referral hospital in Egypt. A total of 100 patients clinically suspected of having CF were recruited from the CF clinic of the Allergy and Pulmonology Unit, Children’s Hospital, Cairo University, Egypt, throughout a 2 year period. Sweat chloride testing was done for all patients using the Wescor macroduct system for collection of sweat. Quantitative analysis for chloride was then done by the thiocyanate colorimetric method. Patients positive for sweat chloride (⩾60 mmol/L) were tested for the ΔF508 mutation using primer specific PCR for cystic fibrosis transmembrane conductance regulator (CFTR) gene. Thirty-six patients (36%) had a positive sweat chloride test. The main clinical presentations in patients were chronic cough in 32 (88.9%), failure to thrive in 27 (75%), steatorrhea in 24 (66.7%), and hepatobiliary involvement in 5 (13.9%). Positive consanguinity was reported in 50% of CF patients. Thirty-two patients were screened for ΔF508 mutation. Positive ΔF508 mutation was detected in 22 (68.8%) patients, 8 (25%) were homozygous, 14 (43.8%) were heterozygous, and 10 (31.3%) tested were negative. CF was diagnosed in more than third of patients suspected of having the disease on clinical grounds. This high frequency of CF among referred patients indicates that a high index of suspicion and an increasing availability of diagnostic tests lead to the identification of a higher number of affected individuals. Elsevier 2014-09 2013-07-15 /pmc/articles/PMC4294314/ /pubmed/25685524 http://dx.doi.org/10.1016/j.jare.2013.07.005 Text en © 2013 Production and hosting by Elsevier B.V. on behalf of Cairo University. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Original Article
El-Falaki, Mona M.
Shahin, Walaa A.
El-Basha, Noussa R.
Ali, Aliaa A.
Mehaney, Dina A.
El-Attar, Mona M.
Profile of cystic fibrosis in a single referral center in Egypt
title Profile of cystic fibrosis in a single referral center in Egypt
title_full Profile of cystic fibrosis in a single referral center in Egypt
title_fullStr Profile of cystic fibrosis in a single referral center in Egypt
title_full_unstemmed Profile of cystic fibrosis in a single referral center in Egypt
title_short Profile of cystic fibrosis in a single referral center in Egypt
title_sort profile of cystic fibrosis in a single referral center in egypt
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294314/
https://www.ncbi.nlm.nih.gov/pubmed/25685524
http://dx.doi.org/10.1016/j.jare.2013.07.005
work_keys_str_mv AT elfalakimonam profileofcysticfibrosisinasinglereferralcenterinegypt
AT shahinwalaaa profileofcysticfibrosisinasinglereferralcenterinegypt
AT elbashanoussar profileofcysticfibrosisinasinglereferralcenterinegypt
AT alialiaaa profileofcysticfibrosisinasinglereferralcenterinegypt
AT mehaneydinaa profileofcysticfibrosisinasinglereferralcenterinegypt
AT elattarmonam profileofcysticfibrosisinasinglereferralcenterinegypt